Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Healthcare Settings

Reference list

Footnote 1

Jackson MM, Lynch P. Isolation practices: A historical perspective. Am J Infect Control 1985;13:21-31.

(1)

Footnote 2

CDC. Isolation techniques for use in hospitals. 2nd ed. Washington: US Government; 1975.

(2)

Footnote 3

Garner JS. Guideline for isolation precautions in hospitals. Part I, Evolution of isolation practices. Am J Infect Control 1996;24:24-52.

(3)

Footnote 4

Schaffner W. Infection control: Old myths and new realities. Infect Control 1980;1:330-4.

(4)

Footnote 5

Goldmann DA. The role of barrier precautions in infection control. J Hosp Infect 1991;18 (Suppl A):515-23.

(5)

Footnote 6

Haley RW, Garner JS, Simmons BP. A new approach to the isolation of hospitalized patients with infectious diseases: alternative systems. J Hosp Infect 1985;6:128-39.

(6)

Footnote 7

Anonymous. Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet 1984;2:1376-7.

(7)

Footnote 8

CDC. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(2S):1S-18S.

(8)

Footnote 9

CDC. Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health-care settings. MMWR 1988;37:377-88.Lynch P, Jackson MM, Cummings MJ, et al. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107:243-6.

(9)

Footnote 10

Lynch P, Jackson MM, Cummings MJ, et al. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107:243-6.

(10)

Footnote 11

Lynch P, Cummings JM, Roberts PL. Implementing and evaluating a system of generic infection precautions: Body substance isolation. Am J Infect Control 1990;18:1-12.

(11)

Footnote 12

Jackson MM, Lynch P. An attempt to make an issue less murky: A comparison of four systems for infection precautions. Infect Control Hosp Epidemiol 1991;12:448-50.

(12)

Footnote 13

Garner JS, Hughes JM. Options for isolation precautions. Ann Intern Med 1987;107:248-50.

(13)

Footnote 14

Garner JS, Simmons BP. Guideline for isolation precautions in hospitals. Infect Control 1983;4:245-325.

(14)

Footnote 15

Siegel J, Rhinehart E, Jackson M, et al. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. 2007.

(15)

Footnote 16

Health and Welfare Canada. Infection control guidelines for isolation and precaution techniques: 1990. CCDR 1990.

(16)

Footnote 17

Health and Welfare Canada. Recommendations for the prevention of the transmission of HIV. CDWR 1987;I3S3(November):1-10.

(17)

Footnote 18

Health and Welfare Canada. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B and other bloodborne pathogens in health-care settings. CDWR 1988;14:117-24.

(18)

Footnote 19

Health and Welfare Canada. Universal precautions: Report of a consensus committee meeting. CDWR 1989;155:23-8.

(19)

Footnote 20

Health Canada. Infection control guidelines for long term care facilities. Part of the Infection Control Guidelines Series. Ottawa, ON: Canada Communications Group; 1994.

(20)

Footnote 21

Public Health Agency of Canada (formerly Health Canada). Guidelines for preventing the transmission of tuberculosis in Canadian health care facilities and other institutional settings. 1996. Report No.: 22S1.

(21)

Footnote 22

Public Health Agency of Canada (formerly Health Canada). Infection control guideline for preventing the transmission of bloodborne pathogens in health care and public services settings. Part of the Infection Control Guidelines Series. 1997. Report No.: 23S3.

(22)

Footnote 23

Public Health Agency of Canada (formerly Health Canada). Infection control guidelines for preventing the spread of vancomycin-resistant enterococci (VRE) in Canada. Part of the Infection Control Guidelines Series. 1997. Report No.: 23S8.

(23)

Footnote 24

Public Health Agency of Canada (formerly Health Canada). Infection control guidelines: Routine practices and additional precautions for preventing the transmission of infection in health care. CCDR 1999;25S4:1-142.

(24)

Footnote 25

Evans R, Lloyd JF, Abouzelof RH, et al. System-wide Surveillance for Clinical Encounters by Patients Previously Identified with MRSA and VRE. Medinfo 2004;2004:212-6.

(25)

Footnote 26

Tien H, Battad A, Bryce E, et al. Multi-drug resistant Acinetobacter in critically injured Canadian forces soldiers. Brit Med J 2007;7:1471-2334.

(26)

Footnote 27

Zoutman DE, Ford D, Bryce E, et al. The state of infection surveillance and control in Canadian acute care hospitals. Am J Infect Control 2003;31:266-73.

(27)

Footnote 28

Gravel D, Matlow A, Ofner-Agnostini M, et al. A point prevalence survey of health care-associated infections in pediatric populations in major Canadian acute care hospitals. AJIC 2007;35:157-62.

(28)

Footnote 29

Gravel D, Taylor G, Ofner M, et al. A point prevalence survey for adult healthcare associated infections within Canadian adult acute care hospitals. J Hosp Infect 2007;66:243-8.

(29)

Footnote 30

Yokoe D, et al. Improving Patient Safety Through Infection Control; A New Healthcare Imperative. Infect Control Hosp Epidemiol 2008;29(Suppl):S3-S11.

(30)

Footnote 31

Lo E, Nicolle L, et al. Strategies to Prevent Catheter-Associated Urinary Tract Infection in Acute Care Hospitals. Infect Control Hosp Epidemiol 2008;29:S41-S50.

(31)

Footnote 32

Coffin S, et al. Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals. Infect Control Hosp Epidemiol 2008;29(Suppl 1):S31-S40.

(32)

Footnote 33

Lim S.P-S. The financial impact of hospital-acquired methicillin-resistant staphylococcus aureus: an incremental cost and cost-effectiveness analysis. Toronto: University of Toronto; 2006.

(33)

Footnote 34

Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.

(34)

Footnote 35

Kirkland KB. Adverse effects of contact isolation. Lancet 1999;354:1177-8.

(35)

Footnote 36

Tarzi S, Kennedy P, Stone S, et al. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 2001;49:250-4.

(36)

Footnote 37

Evans HL, Shaffer MM, Hughes MG, et al. Contact isolation in surgical patients: A barrier to care? Surgery 2003;134:180-8.

(37)

Footnote 38

Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. J Am Med Assoc 2003;290:1899-905.

(38)

Footnote 39

Saint S, Higgins LA, Nallamothu BK, et al. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003;31:354-6.

(39)

Footnote 40

Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol 1996;17:47-52.

(40)

Footnote 41

Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 1996;17:236-48.

(41)

Footnote 42

Jernigan JA, Siegman-Igra Y, Guerrant RC, et al. A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections. Infect Control Hosp Epidemiol 1998;19:494-9.

(42)

Footnote 43

Kaatz G, Gitlin S, Schaberg D, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127:1289-94.

(43)

Footnote 44

Kothary M, Babu U. Infective dose of foodborne pathogens in volunteers: A review. J Food Safety 2001;W1:49-73.

(44)

Footnote 45

Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003;24(Suppl 5):S6-S52.

(45)

Footnote 46

Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. Can Med Assoc J 2003;169:285-92.

(46)

Footnote 47

Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614-24.

(47)

Footnote 48

Hall CB. Nosocomial respiratory syncytial virus infections: The "cold war" has not ended. Clin Infect Dis 2000;31:590-6.

(48)

Footnote 49

Campbell J, Zaccaria E, Mason E, et al. Epidemiological analysis defining concurrent outbreaks of Serratia marcescens and methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1998;19:924-8.

(49)

Footnote 50

Pena C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum -lactamases. Antimicrob Agents Chemother 1998;42:53-8.

(50)

Footnote 51

Bonten M, Kollef M, Hall J. Risk factors for ventilator-associated pneumonia: From epidemiology to patient management. Clin Infect Dis 2004;38:1141-9.

(51)

Footnote 52

Jensenius M, Ringertz SH, Berild D, et al. Prolonged nosocomial outbreak of hepatitis A arising from an alcoholic with pneumonia. Scand J Infect Dis 1998;30:119-23.

(52)

Footnote 53

Zawacki A, O'Rouke E, Potter-Bynoe G, et al. An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker. Infect Control Hosp Epidemiol 2004;25:1083-9.

(53)

Footnote 54

Foca M, Jakob K, Whittier S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Eng J Med 2000;343:695-700.

(54)

Footnote 55

Gupta A, Della-Latta P, Todd B, et al. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails. Infect Control Hosp Epidemiol 2004;25:210-5.

(55)

Footnote 56

Boyce JM, Opal SM, Potter-Bynoe G, et al. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993;17:496-504.

(56)

Footnote 57

Fliegel P, Weinstein W. Rubella outbreak in a prenatal clinic: Management and prevention. Am J Infect Control 1982;10:29-33.

(57)

Footnote 58

Atkinson WL, Markowitz LE, Adams NC, et al. Transmission of measles in medical settings – United States, 1985-1989. Am J Med 1991;91(Suppl 3B):320S-4S.

(58)

Footnote 59

Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomised controlled trial. Lancet 2000;355:97.

(59)

Footnote 60

CDC, MMWR. Outbreaks of pertussis associated with hospitals—Kentucky, Pennsylvania, and Oregon, 2003. MMWR 2003;54:67-71.

(60)

Footnote 61

Mermel LA, McKay M, Dempsey J, et al. Pseudomonas surgical-site infections linked to a healthcare worker with onychomycosis. Infect Control Hosp Epidemiol 2003;24:749-52.

(61)

Footnote 62

Barnes GL, Callaghan SL, Kirkwood CD, et al. Excretion of serotype G1 rotavirus strains by asymptomatic staff. J Pediatr 2003;142:722-5.

(62)

Footnote 63

Wang J, et al. A hospital-acquired outbreak of MRSA initiated by a surgeon carrier. J Hosp Infect 2001;47:104-9.

(63)

Footnote 64

Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: Possible spread by a hospital visitor. Am J Dis Child 1980;134:520-1.

(64)

Footnote 65

Christie CD, Glover AM, Willke MJ, et al. Containment of pertussis in the regional pediatric hospital during the greater Cincinnati epidemic. Infect Control Hosp Epidemiol 1993;16:556-63.

(65)

Footnote 66

Munoz FM, Ong L, Seavy D, et al. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children's hospital. Infect Control Hosp Epidemiol 2002;23:568-72.

(66)

Footnote 67

Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778-82.

(67)

Footnote 68

Saiman L, O'Keefe M, Graham III PL, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003;37:1313-9.

(68)

Footnote 69

Grabsch E, et al. Risk of Environmental and Health Care Worker Contamination with Vancomycin-Resistant enterococci during Outpatient Procedures and Hemodialysis. Infect Control Hosp Epidemiol CHE 2006;27:287-93.

(69)

Footnote 70

Boyce JM, Potter-Bynoe G, Chenevert C, et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: Possible infection control implications. Infect Control Hosp Epidemiol 1997;18:622-7.

(70)

Footnote 71

Lefebvre SL, et al. Guideline for animal-assisted intervention in health care facilities. Am J Infect Control 2008;36:78-85.

(71)

Footnote 72

Sehulster L, Chinn RYW. Guidelines for environmental infection control in health-care facilities. MMWR 2003;52(RR-10):1-44.

(72)

Footnote 73

Vitale CB, Gross TL, Weese JS. Methicillin-Resistant Staphylococcus aureus in Cat and Owner (Letter). Emerg Infect Dis 2006;12:1998-2000.

(73)

Footnote 74

Lefebvre SL, Weese JS. Contamination of Pet Therapy Dogs with MRSA and Clostridium difficile. J Hosp Infect 2009;72:268-9.

(74)

Footnote 75

Bean B, Moore BM, Sterner B, et al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;146:47-51.

(75)

Footnote 76

Brady MT, Evans J, Cuartas J. Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control 1990;18:18-23.

(76)

Footnote 77

Hall CB, Douglas RG. Modes of transmission of respiratory syncytial virus. J Pediatr 1981;99:100-3.

(77)

Footnote 78

Ansari SA. Survival and vehicular spread of human rotaviruses; Possible relation to seasonality of outbreaks. Rev Infect Dis 1991;13:448-61.

(78)

Footnote 79

Moe K, et al. The effects of relative humidity and temperature on the survival of human rotavirus in faeces. Arch Virol 1982;72:179-86.

(79)

Footnote 80

Keswick BH, Pickering LK, DuPont HL, et al. Survival and detection of rotaviruses on environmental surfaces in day care centers. Appl Environ Microbiol 1983;46:813-6.

(80)

Footnote 81

Sattar SA, Lloyd-Evans N, Springthorpe VS, et al. Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J Hyg 1986;96:277-89.

(81)

Footnote 82

Gerding D, Johnson S, Peterson L, et al. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459-77.

(82)

Footnote 83

Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998;26:1027-36.

(83)

Footnote 84

Jawad A, Seifert H, Snelling AM, et al. Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36:1938-41.

(84)

Footnote 85

Wisplinghoff H, Schmitt R, Wohrmann A, et al. Resistance to Disinfectants in Epidemiologically Defined Clinical Isolates of Acinetobacter baumannii. J Hosp Infect 2007;66:174-81.

(85)

Footnote 86

Manian FA, Meyer L, Jenne J. Clostridium difficile contamination of blood pressure cuffs: A call for a closer look at gloving practices in the era of universal precautions. Infect Control Hosp Epidemiol 1996;17:180-2.

(86)

Footnote 87

Myers MG. Longitudinal evaluation of neonatal nosocomial infections: Association of infection with a blood pressure cuff. Pediatrics 1978;61:42-5.

(87)

Footnote 88

Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.

(88)

Footnote 89

Porwancher R, Sheth A, Remphrey S, et al. Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer. Infect Control Hosp Epidemiol 1997;18:771-3.

(89)

Footnote 90

Brooks S, Khan A, Stoica D, et al. Reduction in vancomycin-resistant enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol 1998;19:333-6.

(90)

Footnote 91

Schultsz C, et al. Ultra-sonic nebulizers as a potential source of methicillin-resistant Staphylococcus aureus causing an outbreak in a university tertiary care hospital. Hosp Infect 2003;55:269-75.

(91)

Footnote 92

CDC. Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices – Ohio and New York City 1996. MMWR 1997;47:217-21.

(92)

Footnote 93

Buttery JP, Alabaster SJ, Heine RG, et al. Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys. Pediatr Infect Dis J 1998;17:509-13.

(93)

Footnote 94

Health Canada. Vancomycin-resistant enterococci on a renal ward in an Ontario hospital. CCDR 1996;22-15:125-8.

(94)

Footnote 95

Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.

(95)

Footnote 96

Noskin GA, Bednarz P, Suriano T, et al. Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: Implications for upholstery selection in hospitals. Am J Infect Control 2000;28:311-3.

(96)

Footnote 97

Weems JJ. Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol 1993;14(10):583-6.

(97)

Footnote 98

Zachary KC, Bayne PS, Morrison VJ, et al. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2001;22:560-4.

(98)

Footnote 99

Smith MA, Mathewson JJ, Ulert A, et al. Contaminated stethoscopes revisited. Arch Intern Med 1996;156:82-4.

(99)

Footnote 100

Dias CAG, Kader IA, d'Azevedo P, et al. Detection of methicillin-resistant Staphylococcus aureus (MRSA) in stethoscopes. Revista de Microbiologia 1997;28:82-4.

(100)

Footnote 101

Wright IMR, Orr H, Porter C. Stethoscope contamination in the neonatal intensive care unit. J Hosp Infect 1995;29:65-8.

(101)

Footnote 102

Jones JS, Hoerle D, Riekse R. Stethoscopes: A potential vector of infection? Ann Emerg Med 1995;26:296-9.

(102)

Footnote 103

Marinella MA, Pierson C, Chenoweth C. The stethoscope: A potential source of nosocomial infection? Arch Intern Med 1997;157:786-90.

(103)

Footnote 104

Cohen HA, Amir J, Matalon A, et al. Stethoscopes and otoscopes – a potential vector of infection? Fam Pract 1997;14:446-9.

(104)

Footnote 105

Devine J, Cooke RP, Wright E. Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nococomial MRSA transmission and handwashing compliance? J Hosp Infect 2001;48:72-5.

(105)

Footnote 106

Rutala WA, White M, Gergen MF, et al. Bacterial contamination of keyboards: Efficacy and functional impact of disinfectants. Infect Control Hosp Epidemiol 2006;27:372-7.

(106)

Footnote 107

Neely AN, Maley M, Warden G. Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin Infect Dis 1999;29(5):1358-60.

(107)

Footnote 108

Neely AN, Weber JM, Daviau P, et al. Computer equipment used in patient care within a multihospital system: Recommendations for cleaning and disinfection. Am J Infect Control 2005;33:233-7.

(108)

Footnote 109

Bures S, Fishbain JT, Uyehara CFT, et al. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 2000;28:465-71.

(109)

Footnote 110

Avila-Aguero ML, et al. Toys in a pediatric hospital: Are they a bacterial source? Am J Infect Control 2004;32:287-90.

(110)

Footnote 111

Merriman E, Corwin P, Ikram R. Toys are a potential source of cross-infection in general practitioners' waiting rooms. Br J Gen Pract 2002;52:138-40.

(111)

Footnote 112

Davies MW, Mehr S, Garland S, et al. Bacterial colonization of toys in neonatal intensive care cots. Pediatr 2000;106:e18.

(112)

Footnote 113

Hardy K, et al. A study of the relationship between environmental contamination with methicillin-resistant staphylococcus aureus (MRSA) and patients' acquisition of MRSA. Infect Control Hosp Epidemiol 2006;27:127-32.

(113)

Footnote 114

Griffiths R, et al. Reservoirs of MRSA in the acute hospital setting; A systematic review. Contemp Nurse 2002;13:38-49.

(114)

Footnote 115

Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003;51 Suppl 3:13-21.

(115)

Footnote 116

Byers KE, Durbin LJ, Simonton BM, et al. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1998;19:261-4.

(116)

Footnote 117

Palmer R. Bacterial contamination of curtains in clinical areas. Nurs Stand 1999;14:33-5.

(117)

Footnote 118

Patel S. Minimising cross-infection risks associated with beds and mattresses. Nurs Times 2005;101:52-3.

(118)

Footnote 119

Perry C, et al. Bacterial contamination of uniforms. J Hosp Infect 2001;48:238-41.

(119)

Footnote 120

Jacob G. Uniforms and Workwear – An Evidence Base for Developing Local Policy. 2007.

(120)

Footnote 121

Panhotra BR, Saxena AK, Al-Mulhim AS. Contamination of patients' files in intensive care units: An indication of strict handwashing after entering case notes. Am J Infect Control 2005;33:398-401.

(121)

Footnote 122

Xie X, Li Y, Chwang ATY, et al. How far droplets can move in indoor environments – Revisiting the Wells evaporation-falling curve. Indoor Air 2007;17:211-25.

(122)

Footnote 123

Lindsley WG, Blachere FM, Davis KA, et al. Distribution of Airborne Influenza Virus and Respiratory Syncytial Virus in an Urgent Care Medical Clinic. Clin Infect Dis 2010;50:693-8.

(123)

Footnote 124

Public Health Agency of Canada (formerly Health Canada). Canadian Pandemic Influenza Plan for the Health Sector: Annex F – Prevention and Control of Influenza During a Pandemic: All Healthcare Setting. Ottawa, Ontario; 2011.

(124)

Footnote 125

Roy CJ, Milton DK. Airborne transmission of communicable infection – The elusive pathway. N Eng J Med 2004;350:1710-2.

(125)

Footnote 126

Hendley JO, Wenzel RP, Gwaltney JM. Transmission of rhinovirus colds by self-inoculation. N Eng J Med 1973;288:1361-4.

(126)

Footnote 127

Hall CB, Douglas RG, Schnabel KC, et al. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 1981;33:779-83.

(127)

Footnote 128

Larsen RA, Jacobson JT, Jacobson JA, et al. Hospital-associated outbreak of pharyngitis and conjunctivitis caused by adenovirus. J Infect Dis 1986;154:706-9.

(128)

Footnote 129

Bhalla A, Pultz NJ, Gries DM, et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004;25:164-7.

(129)

Footnote 130

Duckro AN, Blom DW, Lyle EA, et al. Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med 2005;165:302-7.

(130)

Footnote 131

Desenclos J-C, Bourdiol-Razes M, Rolin B, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: Possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001;22:701-7.

(131)

Footnote 132

CDC, MMWR. Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities –Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR 2005;54:220-3.

(132)

Footnote 133

Hall CB, Douglas RG, Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 1980;141:98-102.

(133)

Footnote 134

Hamburger M, Robertson OH. Expulsion of group A hemolytic streptococci in droplets and droplet nuclei by sneezing, coughing and talking. Am J Med 1948;4:690.

(134)

Footnote 135

Feigin RD, Baker C, Herwaldt LA, et al. Epidemic meningococcal disease in an elementary-school classroom. N Eng J Med 1982;307:1255-7.

(135)

Footnote 136

Expert Panel on Influenza and Personal Protective Respiratory Equipment. Influenza transmission and the role of personal protective respiratory equipment: an assessment of the evidence. Council of Canadian Academies 2007. Available from: URL: http://www.scienceadvice.ca/documents/

(136)

Footnote 137

Leclair JM, Zaia JA, Levin MJ, et al. Airborne transmission of chickenpox in a hospital. N Eng J Med 1980;302:450-3.

(137)

Footnote 138

Beck-Sagué C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: Factors in transmission to staff and HIV-infected patients. J Am Med Assoc 1992;268:1280-521.

(138)

Footnote 139

Riley RL, Mills CC, Nyka W, et al. Aerial Dissemination of Pulmonary Tuberculosis – A Two-Year Study of Contagion in a Tuberculosis Ward. Am J Hyg 1959;70:185-96.

(139)

Footnote 140

Haley CE, McDonald RC, Rossi L, et al. Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol 1989;10:204-10.

(140)

Footnote 141

Bloch AB, Orenstein WA, Ewing WM, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics 1985;75:676-83.

(141)

Footnote 142

Ehresmann KR, Hedberg CW, Grimm MB, et al. An outbreak of measles at an international sporting event with airborne transmission in a domed stadium. J Infect Dis 1995;171:679-83.

(142)

Footnote 143

Gelfand HM, Posch J. The recent outbreak of smallpox in Meschede, West Germany. Am J Epidemiol 1971;93:234-7.

(143)

Footnote 144

Wehrle PF, Posch J, Richter KH, et al. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Org 1970;43:669-79.

(144)

Footnote 145

Remington PL, Hall WN, Davis IH, et al. Airborne transmission of measles in a physician's office. J Am Med Assoc 1985;253:1574-7.

(145)

Footnote 146

Canadian Standards Association. Special Requirements for Heating, Ventilation and Air Conditioning (HVAC) Systems in Health Care Facilities (Z317.2-10). Canadian Standards Association, Toronto; 2010. Report No.: Z317.2-10.

(146)

Footnote 147

ANSI, ASHRAE, ASHE. Ventilation of Health Care Facilities. 2008. Report No.: 170-2008 (Addendum b).

(147)

Footnote 148

World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. World Health Organ 2007;WHO/CDS/EPR/2007.6.

(148)

Footnote 149

Tang JW, Li Y, Eames I, et al. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect 2006;64:100-14.

(149)

Footnote 150

Fowler RA. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 2004;169:1198-202.

(150)

Footnote 151

Scales DC, Green K, Chan AK, et al. Illness in intensive-care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1205-10.

(151)

Footnote 152

Christian MD, Loutfy M, McDonald LC, et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004;10:287-93.

(152)

Footnote 153

Catanzaro A. Preventing nosocomial transmission of tuberculosis. Lancet 1995;345:204-5.

(153)

Footnote 154

Larson JL, Ridzon R, Hannan MM. Sputum induction versus fiberoptic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 2001;163:1279-80.

(154)

Footnote 155

Yu I, Wong TW, Chiu Y. Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients. Clin Infect Dis 2005;40:1237-43.

(155)

Footnote 156

Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of any early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003;52:715-20.

(156)

Footnote 157

Yu I. Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? Clin Infect Dis 2007;44:1017-25.

(157)

Footnote 158

Beggs CB. The transmission of tuberculosis in confined spaces: an analytical review of alternative epidemiological models. Int J Tuberc Lung Dis 2003;7:1015-26.

(158)

Footnote 159

Lee B. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Eng J Med 2003;348:1986-94.

(159)

Footnote 160

Evans D. Epidemiology and etiology of occupational infectious disease. In: Couturier A, editor. Occupational and environmental infectious diseases: epidemiology, prevention and clinical management.Beverly Farms, MA: OEM Press; 2000. p. 37-132.

(160)

Footnote 161

Leffel EK, Reed DS. Marburg and Ebola Viruses as Aerosol Threats. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2004;2:186-91.

(161)

Footnote 162

Hutton MD, Stead WW, Cauthen GM, et al. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 1990;161:286-95.

(162)

Footnote 163

Frampton MW. An outbreak of tuberculosis among hospital personnel caring for a patient with a skin ulcer. Ann Intern Med 1992;117:312-3.

(163)

Footnote 164

Keijman J, Tjhie J, Damink SO, et al. Unusual nosocomial transmission of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2001;20:808-9.

(164)

Footnote 165

Kantor HS, Poblete R, Pusateri SL. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 1988;84:833-8.

(165)

Footnote 166

Burton JL. Health and safety at necropsy. J Clin Pathol 2003;56:254-60.

(166)

Footnote 167

Alter MJ, Ahtone J, Maynard JE. Hepatitis B virus transmission associated with multiple-dose vial in a hemodialysis unit. Ann Intern Med 1983;99:330-3.

(167)

Footnote 168

Plott R, Wagner R, Tyri S. Iatrotgenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol 1990;126:1441-4.

(168)

Footnote 169

Comstock R, Mallonee S, Fox J, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 2004;25:576-83.

(169)

Footnote 170

Samandari T, Malakmadze N, Balter S, et al. A large outbreak of hepatitis B virus infections associated with frequent injections at a physicians's office. ICHE 2005;26:745-50.

(170)

Footnote 171

Germain J-M, Carbonne A, Thiers V, et al. Germain JM et al. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anaesthesia. Infect Control Hosp Epidemiol 2005;26:789-92.

(171)

Footnote 172

CDC, MMWR. Transmission of hepatitis B and C viruses in outpatient settings – New York, Oklahoma, and Nebraska, 2000-2002. MMWR 2003;52:901-6.

(172)

Footnote 173

Al-Saigul AM, Fontaine RE, Haddad Q. Nosocomial malaria from contamination of a multidose heparin container with blood. Infect Control Hosp Epidemiol 2000;21:329-30.

(173)

Footnote 174

Abulrahi HA, Bohlega MAH, Fontaine RE, et al. Plasmodium falciparum malaria transmitted in hospital through heparin locks. The Lancet 1997;349:23-5.

(174)

Footnote 175

Beckendorf R, Klotz S, Hinkle N, et al. Nasal myiasis in an intensive care unit linked to hospital-wide mouse infestation. Arch Intern Med 2002;162:1-3.

(175)

Footnote 176

Thomsen RW, Hundborg HH, et al. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: A population-based case-control study. Diabetes Care 2004;27:1143-7.

(176)

Footnote 177

Carton J, Maradona J, Nuno F, et al. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1992;1:281-7.

(177)

Footnote 178

Hirschtick R, Glassroth J, Jordan M, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Eng J Med 1995;333:845-51.

(178)

Footnote 179

Malone J, Ijaz K, Lambert L, et al. Investigation of healthcare-associated transmission of Mycobacterium tuberculosis among patients with malignancies at three hospitals and at a residential facility. Cancer 2004;101:2713-21.

(179)

Footnote 180

Safdar N, Kluger DM, Maki DG. A review of risk factors for catheterrelated bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine 2002;81:466-79.

(180)

Footnote 181

Jarvis WR, Robles B. Nosocomial infections in pediatric patients. Adv Pediatr Infect Dis 1996;243-95.

(181)

Footnote 182

Yogaraj JS, Elward AM, Fraser VJ. Rate, risk factors, and outcomes of nosocomial primary bloodstream infection in pediatric intensive care units patients. Pediatr 2002;110:481-5.

(182)

Footnote 183

Greene JN. The microbiology of colonization, including techniques for assessing and measuring colonization. Infect Control Hosp Epidemiol 1996;17:114-8.

(183)

Footnote 184

Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.

(184)

Footnote 185

Bonten MJ, Slaughter S, Hayden MK, et al. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med 1998;26:2001-4.

(185)

Footnote 186

Flynn D, Weinstein R, Nathan C, et al. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis 1987;156:363-8.

(186)

Footnote 187

Olson B, Weinstein RA, Weinstein RA, et al. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis 1984;150:808-16.

(187)

Footnote 188

Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Eng J Med 2002;346:1871-7.

(188)

Footnote 189

Toltzis P, Hoyen C, et al. Factors that predict preexisting colonization with antibiotic-resistant gram-negative bacilli in patients admitted to a pediatric intensive care unit. Pediatr 1999;103:719-23.

(189)

Footnote 190

Sarginson RE, Taylor N, Reilly N, et al. Infection in prolonged pediatric critical illness: A prospective four-year study based on knowledge of the carrier state. Crit Care Med 2004;32:839-47.

(190)

Footnote 191

Silvestri L, Monti Bragadin C, Milanese M, et al. Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients. J Hosp Infect 1999;42:125-33.

(191)

Footnote 192

Heggers J, Pillips L, Boertman J, et al. The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center. J Burn Care Rehab 1988;9:610-2.

(192)

Footnote 193

Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004;39:219-26.

(193)

Footnote 194

Didier ME, Havighurst T, Maki DG. Epidemiology of nosocomial infection caused by multi-resistant ESBL-producing klebsiella (Abstract 50). Program and abstracts of the IDSA 34th Annual Meeting , 868. 1996.
Ref Type: Abstract

(194)

Footnote 195

Lai KK, Fontecchio SA, Kelley AL, et al. The epidemiology of fecal carriage of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18:762-5.

(195)

Footnote 196

Montecalvo MA, de Lencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680-5.

(196)

Footnote 197

Public Health Agency of Canada (formerly Health Canada). Construction-related nosocomial infections in patients in health care facilities: Decreasing the risk of aspergillus legionella and other infections. CCDR 2001;27S:1-60.

(197)

Footnote 198

CHICA-Canada Healthcare Facility Design and Construction Interest Group. CHICA-CANADA Position Statement – Healthcare Facility Design Position Statement (Accessed 16-March-2009). CHICA-Canada 2008:1-7. Available from: URL: http://www.chica.org/pdf/HFDposition.pdf

(198)

Footnote 199

Noskin GA, Peterson LR. Engineering infection control through facility design. Emerg Infect Dis 2001;7:354-7.

(199)

Footnote 200

Canadian Standards Association. Special requirement for plumbing installation in health care facilities. 2009. Report No.: Z317.1-09.

(200)

Footnote 201

Facility Guidelines Institute, US Department of Health and Human Services. Guidelines for Design and Construction of Health Care Facilities. 2010.

(201)

Footnote 202

Canadian Standards Association. Guidelines for the Design and Construction of Canadian Health Care Facilities. Canadian Standards Association; 2011. Report No.: Z8000-11.

(202)

Footnote 203

Canadian Standards Association. Infection control during construction or renovation of health care facilities. 2003. Report No.: Z317.13-03.

(203)

Footnote 204

Colville A, Weaving P, Cooper T. How infection prevention professionals can make it easier for designers and planners. Brit J Infect Control 2007;8:22-4.

(204)

Footnote 205

Bartley JM, The 1997 1a1AGC. APIC state-of-the-art report: the role of infection control during construction in health care facilities. Am J Infect Control 2000;28:156-69.

(205)

Footnote 206

Cheng SM, Streifel AJ. Infection control considerations during construction activities: land excavation anf demolition. Am J Infect Control 2001;29:321-8.

(206)

Footnote 207

Jensen PA, Lambert L, Iademarco M, et al. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR 2005;54:1-141.

(207)

Footnote 208

Calder RA, Duclos P, Wilder MH, et al. Mycobacterium tuberculosis transmission in a health clinic. Bull Int Union Tuberc Lung Dis 1991;66:103-6.

(208)

Footnote 209

Coronado V, Beck-Sague C, Hutton M, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: Epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993;168:1052-5.

(209)

Footnote 210

Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: A risk to patients and health care workers. Ann Intern Med 1992;117:191-6.

(210)

Footnote 211

Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis 1982;125:559-62.

(211)

Footnote 212

Menzies D, Fanning A, Yuan L, et al. Tuberculosis Among Health Care Workers. N Eng J Med 1995;332:92-8.

(212)

Footnote 213

Riley RL. Airborne infection. Am J Med 1974;57:466-75.

(213)

Footnote 214

Musher DM. How contagious are common respiratory tract infections? New Eng J Med 2003;348:1256-66.

(214)

Footnote 215

Roberts L, Smith W, Jorm L, et al. Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatr 2000;105:738-42.

(215)

Footnote 216

Public Health Agency of Canada. Infection control guideline for the prevention of healthcare-associated pneumonia. 2010.

(216)

Footnote 217

Public Health Agency of Canada. Hand hygiene practices in health care settings. 2013.

(217)

Footnote 218

Canadian Nurses Association. Position Statement – Overcapacity Protocols and Capacity in Canada's Health System. 2009.

(218)

Footnote 219

Public Health Agency of Canada (formerly Health Canada). Infection control guidelines for the prevention and control of occupational infections in health care. CCDR 2002;28S1:1-264.

(219)

Footnote 220

Petruk J. Time to change our equipment and attitudes. Can Nurs 2003;99:19-22.

(220)

Footnote 221

Beekman SE, Vaughn TE, McCoy KD, et al. Hospital bloodborne pathogens programs: Program characteristics and blood and body fluid exposure rates. Infect Control Hosp Epidemiol 2001;22:73-82.

(221)

Footnote 222

Centers for Disease Control and Prevention (CDC). Workbook for Designing, Implementing, and Evaluating a Sharps Injury Prevention Program. 2008.

(222)

Footnote 223

Bryce EA, Ford J, Chase L, et al. Sharps injuries: defining prevention priorities. Am J Infect Control 1999;27:447-52.

(223)

Footnote 224

Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of Bloodstream Infection Temporally Associated with the Use of an Intravascular Needleless Valve. Clin Infect Dis 2007;44:1408-14.

(224)

Footnote 225

Salgado CD, Chinnes L, Paczesny TH, et al. Increased Rate of Catheter-Related Bloodstream Infection Associated with Use of a Needless Mechanical Valve Device at a Long-Term Acute Care Hospital. Infect Control Hosp Epidemiol 2007;28:684-8.

(225)

Footnote 226

Field K, McFarlane C, Cheng AC, et al. Incidence of Catheter-Related Bloodstream Infection Among Patients with a Needleless, Mechanical Valve-Based Intravenous Connector in an Australian Hematology-Oncology Unit. Infect Control Hosp Epidemiol 2007;28:610-3.

(226)

Footnote 227

Maragakis L, Bradley K, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. ICHE 2006;27:67-70.

(227)

Footnote 228

O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections. Centers for Disease Control; 2011.

(228)

Footnote 229

Kellerman S, Shay DK, Howard J, et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 1996;129:711-7.

(229)

Footnote 230

Tokars JI, Cookson ST, McArthur MA, et al. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med 1999;131:340-7.

(230)

Footnote 231

Danzig LE, Short LJ, Collins K, et al. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. J Am Med Assoc 1995;273:1862-4.

(231)

Footnote 232

Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999;179:442-8.

(232)

Footnote 233

Canadian Standards Association. Selection, use, and care of respirators. 2011. Report No.: Z94.4-11.

(233)

Footnote 234

Lawrence RB, Duling MG, Calvert CA, et al. Comparison of performance of three different types of respiratory protection devices. J Occup Environ Hyg 2006;3:465-74.

(234)

Footnote 235

Danyluk Q, Hon CY, Neudorf M, et al. Health Care Workers and Respiratory Protection: Is the User Seal Check a Serrogate for Respirator Fit-Testing? J Occup Environ Hyg 2011;8:267-70.

(235)

Footnote 236

CDC. Laboratory performance evaluation of N95 filtering facepiece respirators, 1996. MMWR 1998;47:1045-9.

(236)

Footnote 237

Henderson E, CHICA-Canada Education Committee. Infection Prevention and Control Core Competencies for Health Care Workers: A Consensus Document Compiled by: Dr. Elizabeth Henderson. 2006.

(237)

Footnote 238

Caffarella R. Planning Programs for Adult Learners: a practical guide for Educators, trainers and Staff Developers, 2nd Edition. 2nd ed. San Francisco CA: Jossey-Bass; 2001.

(238)

Footnote 239

Rutula WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008. CDC (Dept of Health and Human Services USA); 2008.

(239)

Footnote 240

Public Health Agency of Canada (formerly Health Canada). Infection Prevention and Control Guideline for Flexible Gastrointestinal Endoscopy and Flexible Bronchoscopy. 2010.

(240)

Footnote 241

Canadian Standards Association. Decontamination of reusable medical devices. Canadian Standards Association; 2000. Report No.: CSA-Z314.8.

(241)

Footnote 242

Canadian Standards Association. Effective sterilization in health care facilities by the steam process. Report No.: Z314.3-09.

(242)

Footnote 243

Canadian Standards Association. Sterilization of health care products – general requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices. 2001. Report No.: CAN/CSA-ISO 14937-01.

(243)

Footnote 244

Canadian Standards Association. Sterilization of health care products – Chemical indicators – Guidance for selection, use and interpretation of results. 2009. Report No.: Z15882-09.

(244)

Footnote 245

Canadian Standards Association. Steam Sterilizers for Health Care Facilities. 2003. Report No.: Z314.7-03 R2008.

(245)

Footnote 246

Spaulding EH. Chemical disinfection of medical and surgical materials. In: Lawrence CA, Block SS, editors. Disinfection, Sterilization and Preservation.Philadelphia: Lea & Febiger; 1968. p. 517-31.

(246)

Footnote 247

Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, editor. Disinfection, sterilization and preservation.Philadelphia: Lea and Febiger; 1991. p. 617-41.

(247)

Footnote 248

Public Health Agency of Canada. Classic Creutzfeldt-Jakob Disease in Canada – Quick Reference Guide 2007. 2007.

(248)

Footnote 249

Health Canada. Classic Creutzfeldt-Jakob Disease in Canada. CCDR 2002;28S5:1-110.

(249)

Footnote 250

Public Health Agency of Canada. Variant Creutzfeldt-Jakob Disease (vCJD) in Canada. Public Health Agency of Canada 2007. Available from: URL: http://www.phac-aspc.gc.ca/cjd-mcj/vcjd-faq-eng.php

(250)

Footnote 251

Polisena J, Hailey D, Moulton K, et al. Reprocessing and Reuse of Single-Use Medical Devices: A National Survey of Canadian Acute-Care Hospitals. Infect Control Hosp Epidemiol 2008;29:437-9.

(251)

Footnote 252

Miller M, Gravel D, Paton S, et al. Reuse of single-use medical devices in Canadian acute-care healthcare facilities, 2001. CCDR 2001;27:1-7.

(252)

Footnote 253

US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health. Appendix B: Definition of Terms. In Guidance for Industry and for FDA Staff – Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals. 2000.

(253)

Footnote 254

Rupp ME., Marion N, Fey P., et al. Outbreak of Vancomycin-Resistant Enterococcus faecium in a Neonatal Intensive Care Unit. Infect Control Hosp Epidemiol 2001;22:301-3.

(254)

Footnote 255

Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993;118:117-28.

(255)

Footnote 256

Cryan EMJ, Falkiner FR, Mulvihill TE, et al. Pseudomonas aeuriginosa cross-infection following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1984;5:371-6.

(256)

Footnote 257

O'Connor BH, Bennett JR, Sutton DR, et al. Salmonellosis infection transmitted by fibreoptic endoscopes. Lancet 1982;864-6.

(257)

Footnote 258

Kaczmarek RG, Moore RM, Jr., McCrohan J, et al. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med 1992;92:257-61.

(258)

Footnote 259

Perdelli F, Sartini M, Spagnolo AM, et al. A problem of hospital hygiene: The presence of aspergilli in hospital wards with different air-conditioning features. Am J Infect Control 2006;34:264-8.

(259)

Footnote 260

Layton MC, Perez M, Heald P, et al. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir [see comments]. Infect Control Hosp Epidemiol 1993;14:369-75.

(260)

Footnote 261

Carling PC, Briggs J, Hylander D, et al. An evaluation of patient area cleaning in 3 hospitals using a novel targeting methodology. Am J Infect Control 2006;34:513-9.

(261)

Footnote 262

Malik R, Cooper RA, Griffith CJ. Use of audit tools to evaluate the efficacy of cleaning systems in hospitals. Am J Infect Control 2003;31:181-7.

(262)

Footnote 263

Martinez JA, et al. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 2003;163:1905-12.

(263)

Footnote 264

Wu H-M, Fornek M, Schwab KJ, et al. A norovirus outbreak at a long-term-care facility: The role of environmental surface contamination. Infect Control Hosp Epidemiol 2005;26:802-10.

(264)

Footnote 265

MacCannell T, Umscheid CA, Agarwal RK, et al. Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings. CDC 2010;1-244.

(265)

Footnote 266

Cohen SH, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of American (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.

(266)

Footnote 267

Wilcox MH, Fawley WN, Wigglesworth N, et al. Comparison of the Effect of Detergent Versus Hypochlorite Cleaning on Environmental Contamination and Incidence of Clostridium difficile Infection. J Hosp Infect 2003;54:109-14.

(267)

Footnote 268

Mayfield JL, Leet T, Miller J, et al. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000;31:995-1000.

(268)

Footnote 269

Vonberg R-P, Kuijper EJ, Wilcox MH, et al. Infection Control Measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008;14:2020.

(269)

Footnote 270

Dubberke E, Gerding D, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S81-S92.

(270)

Footnote 271

Hsu J, Abad C, Dinh M, et al. Prevention of Endemic Healthcare-Associated Clostridium difficile Infection: Reviewing the Evidence. Am J Gastroenterol 2010;Advance Online Publication(July 6, 2010):1-13.

(271)

Footnote 272

Rutala WA. Disinfection, sterilization, and waste disposal. In: Wenzel RP, editor. Prevention and control of nosocomial infections.Baltimore: Williams & Wilkins; 1997. p. 539-93.

(272)

Footnote 273

Reinhardt PA, Gordon JG, Alvarado CJ. Medical waste management. In: Mayhall CG, editor. Hospital epidemiology and infection control.Baltimore: Williams & Wilkins; 1996. p. 1099-108.

(273)

Footnote 274

Schmidt EA. Medical waste management. In: Olmsted RN, editor. APIC infection control and applied epidemiology: principles and practice.St. Louis: Mosby; 1996. p. 112-1.

(274)

Footnote 275

Canadian Standards Association. Handling of waste materials in health care facilities and veterinary health care facilities. 2009. Report No.: Z317.10-09.

(275)

Footnote 276

Weinstein SA, Gantz NM, Pelletier C, et al. Bacterial surface contamination of patients' linen: isolation precautions versus standard care. Am J Infect Control 1989;17:264-7.

(276)

Footnote 277

Rhame FS. The inanimate environment. In: Bennett JV, editor. Hospital infections. Fourth Edition ed. Philadelphia: Lippincott –Raven; 1998. p. 299-324.

(277)

Footnote 278

Shiomori T, Miyamoto H, Makishima K, et al. Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination. J Hosp Infect 2002;50:30-5.

(278)

Footnote 279

Sattar SA, Springthorpe S, Mani S, et al. Transfer of bacteria from fabrics to hands and other fabrics: development and application of a quantitative method using Staphylococcus aureus as a model. J Appl Microbiol 2001;90:962-70.

(279)

Footnote 280

Pugliese G. Isolation and double-bagging laundry: is it really necessary? Health Facil Manage 1989;2:8-21.

(280)

Footnote 281

Whyte W, et al. Bacterial contamination on the surface of hospital linen chutes. J Hyg 1969;67:427-35.

(281)

Footnote 282

Michaelsen GS. Designing linen chutes to reduce spread of infectious organisms. Hospitals 1965;39:116-9.

(282)

Footnote 283

Dement J, Pompei L, Ostbye T, et al. An integrated comprehensive occupational surveillance system for health care workers. Am J Ind Med 2004;45:528-38.

(283)

Footnote 284

Loeb M, McGeer A, Henry B, et al. SARS among Critical Care Nurses, Toronto. Emerg Infect Dis 2004;10:251-5.

(284)

Footnote 285

Graman PS, Hall CB. Epidemiology and control of nosocomial viral infections. Infect Dis Clin North Am 1989;3:815-41.

(285)

Footnote 286

Nicolle LE. Nursing home dilemmas. Infect Control Hosp Epidemiol 1997;18:806-8.

(286)

Footnote 287

Levine R, Spaite D, Valenzuela TD, et al. Comparison of clinically significant infection rates among prehospital versus inhospital initiated IV Lines. Ann Emerg MEd 1995;25:502-6.

(287)

Footnote 288

Trick WE, et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001;49:270-6.

(288)

Footnote 289

Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000;31:717-22.

(289)

Footnote 290

Ford-Jones EL, Mindorff C, Gold R, et al. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol 1990;131:711-8.

(290)

Footnote 291

Gaggero A, Avendano L, Fernandez J, et al. Nosocomial transmission of rotavirus from patients admitted with diarrhea. J Clin Microbiol 1992;30:3294-7.

(291)

Footnote 292

Drinka P, Krause P, Nest L, et al. Risk of acquiring influenza A in a nursing home from a culture-positive roommate. Infect Control Hosp Epidemiol 2003;24:872-4.

(292)

Footnote 293

Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant enterococcus: Risk factors and control. Infect Control Hosp Epidemiol 2001;22:140-7.

(293)

Footnote 294

Teltsch DY, Hanley J, Loo V, et al. Infection Acquisition Following Intensive Care Unit Room Privatization. Arch Intern Med 2011;171:32-8.

(294)

Footnote 295

Chaudhury H, Mahmood A, Valente M. Pilot study on comparative assessment of patient care issues in single and multiple occupancy rooms (Unpublished report): The Coalition for Health Environments Research. Unpublished 2003;(1):58.

(295)

Footnote 296

Ulrich R, Quan X, Zimring C, et al. The role of the physical environment in the hospital of the 21st century: a once-in-a-lifetime opportunity. 2004.

(296)

Footnote 297

Bracco D, Dubois MJ, Bouali R, et al. Single Rooms May Help to Prevent Nosocomial Bloodstream Infection and Cross-Transmission of Methicillin-Resistant Staphylococcus aureus in Intensive Care Units. Intensive Care Med 2007;33:836-40.

(297)

Footnote 298

Ben-Abraham R, Keller N, Szold O, et al. Do isolation rooms reduce the rate of nosocomial infections in the pediatric intensive care unit? J Crit Care 2002;17:176-80.

(298)

Footnote 299

Mulin B, Rouget C, Clément C, et al. Association of private isolation rooms with ventilator-associated Acinetobacter baumanii pneumonia in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1997;18:499-503.

(299)

Footnote 300

Hamel M, Zoutman D, O'Callaghan C. Exposure to Hospital Roommates as a Risk Factor for Health Care-Associated Infection. Am J Infect Control 2010;38:173-81.

(300)

Footnote 301

Boyce J, Havill L, Otter J, et al. Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol 2007;28:1142-7.

(301)

Footnote 302

Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin resistant enterococcus in health care facilities in a region. N Eng J Med 2001;344:1427-33.

(302)

Footnote 303

Larson E. Skin hygiene and infection prevention: More of the same or different approaches? Clin Infect Dis 1999;29:1287-94.

(303)

Footnote 304

Larson E. A causal link between handwashing and risk of infection? Examination of the evidence. Infect Control Hosp Epidemiol 1988;9:28-36.

(304)

Footnote 305

Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307-12.

(305)

Footnote 306

Hilburn J, Hammond BS, Fendler EJ, et al. Use of alcohol hand sanitizer as an infection control strategy in an acute care facility. Am J Infect Control 2003;31:109-16.

(306)

Footnote 307

Lam BCC, Lee J, Lau YL. Hand hygiene practices in neonatal intensive care unit: a multimodal intervention and impact on nosocomial infection. Pediatr 2004;114:565-71.

(307)

Footnote 308

Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005;33:392-7.

(308)

Footnote 309

Johnson PDR, Martin R., Burrell LJ, et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust 2005;183:509-14.

(309)

Footnote 310

Larson E, Kretzer EK. Compliance with handwashing and barrier precautions. J Hosp Infect 1995;30:88-106.

(310)

Footnote 311

Teare EL. UK handwashing initiative. J Hosp Infect 1999;43:1-3.

(311)

Footnote 312

Rotter M. Hand washing and hand disinfection. In: Mayhall CG, editor. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1727-46.

(312)

Footnote 313

Ali Y, Dolan MJ, Fendler EJ, et al. Alcohols. In: Block SS, editor. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 229-53.

(313)

Footnote 314

Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-43.

(314)

Footnote 315

Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995;14:510-6.

(315)

Footnote 316

Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000;31:1001-7.

(316)

Footnote 317

Chaiyakunapruk N, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis. Ann Intern Med 2002;136:792-801.

(317)

Footnote 318

Mermel LA, McCormick RD, Springman SR, et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery swan-ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91:197-205.

(318)

Footnote 319

Raad II, Hohn DC, Gilbreath BJ. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-8.

(319)

Footnote 320

Hu KK, et al. Using maximal sterile barriers to prevent central venous catheter-related infection: A systematic evidence-based review. Am J Infect Control 2004;32:142-6.

(320)

Footnote 321

Young EM, Commiskey ML, Wilson SJ. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: A systems-based intervention. Am J Infect Control 2006;34:503-6.

(321)

Footnote 322

Schlesinger J, et al. Streptococcal meningitis after myelography. Arch Neurol 1982;39:576-7.

(322)

Footnote 323

Gelfand MS, et al. Streptococcal meningitis complicating diagnostic myelography: three cases and review. Clin Infect Dis 1995;20:582-7.

(323)

Footnote 324

Veringa E, van Belkum A, Schellekens H. Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J-Hosp-Infect 1995;29:316-8.

(324)

Footnote 325

Schneeberger PM, et al. Alpha-hemolytic streptococci: A major pathogen of iatrogenic meningitis following lumbar puncture. Case reports and a review of the literature. Infection 1996;24:29-33.

(325)

Footnote 326

Yaniv L. Iatrogenic meningitis: An increasing role for resistant viridans streptococci? Case report and review of the last 20 years. Scan J Infect Dis 2000;32:693-6.

(326)

Footnote 327

Hsu J, Jensen B, Arduino M, et al. Streptococcal Meningitis Following Myelogram Procedures. Infect Control Hosp Epidemiol 2007;28:614-7.

(327)

Footnote 328

Couzigou C, Vuong T, Botherel M, et al. Iatrogenic Streptococcus salivarius meningitis after spinal anaesthesia; need for strict application of standard precautions. J Hosp Infect 2003;53:313-4.

(328)

Footnote 329

Baer E. Iatrogenic Meningitis: The Case for Face Masks. Clin Infect Dis 2000;31:519-21.

(329)

Footnote 330

Watankunakorn C, et al. Streptococcus salivarius meningitis following myelography. Infect Control Hosp Epidemiol 1992;13:454.

(330)

Footnote 331

Philips B, et al. Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth 1992;69:407-8.

(331)

Footnote 332

Dolan SA, Felizardo G, Barnes S, et al. APIC Position Paper: Safe Injection, Infusion and Medication Vial Practices in Health Care. Am J Infect Control 2010;38:167-72.

(332)

Footnote 333

Labus B, Sands L, Rowley P, et al. Acute Hepatitis C Virus Infections Attributed to Unsafe Injection Practices at an Endoscopy Clinic – Nevada, 2007. MMWR 2008;57:513-7.

(333)

Footnote 334

Rengasamy A. Respiratory protection against bioaerosols: Literature review and research needs. Am J Infect Control 2004;32:345-54.

(334)

Footnote 335

Ofner M, Lem M, Sarwal S, et al. Cluster of severe acute respiratory syndrome cases among protected health care workers – Toronto, April 2003. Can Commun Dis Rep 2003;29:93-7.

(335)

Footnote 336

Patel S. Principles of Appropriate Use of Disposable Gloves. Nurs Times 2006;102:44-5.

(336)

Footnote 337

Tenorio AR, Badri SM, Sahgal NB, et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant Enterococcus species by health care workers after patient care. Clin Infect Dis 2001;32:826-9.

(337)

Footnote 338

Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88:137-40.

(338)

Footnote 339

Doebbleling BN, Pfaller MA, Houston AK, et al. Removal of nosocomial pathogens from the contaminated glove: Implications for glove reuse and handwashing. Ann Intern Med 1988;109:394-8.

(339)

Footnote 340

Kotilainen H, Brinker J, Avato J, et al. Latex and vinyl examination gloves: Quality control procedures and implications for health care workers. Arch Intern Med 1989;149:2749-53.

(340)

Footnote 341

Korniewicz D, Laughon B, Butz A, et al. Integrity of vinyl and latex procedure gloves. Nurs Res 1989;38:144-6.

(341)

Footnote 342

Pittet D, Dharan S, Touveneau S, et al. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999;159:821-6.

(342)

Footnote 343

Thompson BL, Dwyer DM, Ussery XT, et al. Handwashing and glove use in a long-term-care facility. Infect Control Hosp Epidemiol 1997;18:97-103.

(343)

Footnote 344

Larson E. Compliance with isolation techniques. Am J Infect Control 1983;11:221-5.

(344)

Footnote 345

Girou E, Chai SHT, Oppein F, et al. Misuse of gloves: The foundation for poor compliance with hand hygiene and the potential for microbial transmission? J Hosp Infect 2004;57:162-9.

(345)

Footnote 346

Rego A, Roley L. In-use barrier integrity of gloves: Latex and nitrile superior to vinyl. Am J Infect Control 1999;27:405-10.

(346)

Footnote 347

Korniewicz DM, El-Masri M, Broyles JM, et al. Performance of latex and nonlatex medical examination gloves during simulated use. Am J Infect Control 2002;30:133-8.

(347)

Footnote 348

Brehler R, Kolling R, Webb M, et al. Brehler et al. Glove powder – A risk for the development of latex allergy. Eur J Surg 1997;23-5.

(348)

Footnote 349

Jones RD, Jampani H, Mulberry G, et al. Moisturizing alcohol hand gels for surgical hand preparation. AORN J 2000;71:584-99.

(349)

Footnote 350

Truscott W, Stoessel K. Factors that impact on the infection control capability of gloves. Professional Nurse 2003;18:507-11.

(350)

Footnote 351

Pitten FA, Herdemann G, Kramer A. The integrity of latex gloves in clinical dental practice. Clinical and Epidemiological Studies 2000;28:388-92.

(351)

Footnote 352

Bettin K, Clabots C, Mathie P, et al. Effectiveness of liquid soap vs chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands. Infect Control Hosp Epidemiol 1994;15:697-702.

(352)

Footnote 353

Hagos B, Kibwage IO, Mwongera M, et al. The microbial and physical quality of recycled gloves. East Afr Med J 1997;74:224-6.

(353)

Footnote 354

Lee J, et al. Infection control in a burn center. J Burn Care Rehab 1990;11:575-80.

(354)

Footnote 355

Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on aquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448-56.

(355)

Footnote 356

Duquette-Petersen L. The role of protective clothing in infection prevention in patients undergoing autologous bone marrow transplantation. Oncol Nurs Forum 1999;26:1319-24.

(356)

Footnote 357

Kostiuk N, Ramachandran C. Does gowning prevent infection in the NICU? Can Nurs 2003;99:20-3.

(357)

Footnote 358

Cloney DL, Donowitz LG. Overgown use for infection control in nurseries and neonatal intensive care units. Am J Dis Child 1986;140:680-3.

(358)

Footnote 359

Pelke S, Ching D, Easa D, et al. Gowning does not affect colonization or infection rates in a neonatal intensive care unit. Arch Pediatr Adolesc Med 1994;148:1016-20.

(359)

Footnote 360

Donowitz LG. Failure of the overgown to prevent nosocomial infection in a pediatric intensive care unit. Pediatrics 1986;77:35-8.

(360)

Footnote 361

Birenbaum H, Glorioso L, Rosenberger C, et al. Gowning on a postpartum ward fails to decrease colonization in the newborn infant. Am J Dis Child 1990;144:1031-3.

(361)

Footnote 362

Rush J, Fiorino-Chiovitti R, Kaufman K, et al. A randomized controlled trial of a nursery ritual: Wearing cover gowns to care for healthy newborns. Birth 1990;17:25-30.

(362)

Footnote 363

Kiehl E, Wallace R, Warren C. Tracking perinatal infection: Is it safe to launder your scrubs at home? MCN Am J Matern Child Nurs 1997;22:195-7.

(363)

Footnote 364

Rosen HR. Acquisition of hepatitis C by a conjunctival splash. Am J Infect Control 1997;25:242-7.

(364)

Footnote 365

Hosoglu S, Celen MK, Akalin S, et al. Transmission of hepatitis C by blood splash into conjunctiva in a nurse. Am J Infect Control 2003;31:502-4.

(365)

Footnote 366

CDC. Epidemiologic Notes and Reports Update: Human Immunodeficiency Virus Infections in Health-Care Workers Exposed to Blood of Infected Patients. MMWR 1987;36:285-9.

(366)

Footnote 367

Davidson I, Crisp A, Hinwood D, et al. Eye splashes during invasive vascular procedures. The British Journal of Radiology 1995;68:39-41.

(367)

Footnote 368

Johnson DF, Druce JD, Birch C, et al. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis 2009;49:275-7.

(368)

Footnote 369

Diaz KT, Smaldone GC. Quantifying Exposure Risk: Surgical Masks and Respirators. Am J Infect Control 2010;38:501-8.

(369)

Footnote 370

Gehanno J-F, Kohen-Couderc L, Lemeland J-F, et al. Nosocomial meningococcemia in a physician. Infect Control Hosp Epidemiol 1999;20:564-5.

(370)

Footnote 371

Gilmore A, Stuart J, Andrews N. Risk of secondary meningococcal disease in health-care workers. Lancet 2000;356:1654-5.

(371)

Footnote 372

CDC. Nosocomial meningococcemia. MMWR 1978;27:358.

(372)

Footnote 373

Thomas C. Efficiency of surgical masks in use in hospital wards. Guys Hosp Rep 1961;110:157-67.

(373)

Footnote 374

Downie AW, Meiklejohn M, St.Vincent L, et al. The recovery of smallpox virus from patients and their environment in a smallpox hospital. Bull World Health Org 1965;33:615-22.

(374)

Footnote 375

Capps J. Measures for the prevention and control of respiratory infections in military camps. J Am Med Assoc 1918;71:448-51.

(375)

Footnote 376

Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: Systematic review. Brit Med J 2009;339:b3675.

(376)

Footnote 377

Quinlan B, Loughrey S, Nicklin W, et al. Restrictive visitor policies: feedback from healthcare workers, patients and families. Hosp Q 2003;7:33-7.

(377)

Footnote 378

George RH, Gully PR, Gill O, et al. An outbreak of tuberculosis in a children's hospital. J Hosp Infect 1986;8:129-42.

(378)

Footnote 379

Garcia R, Raad I, Abi-Said D, et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 1997;18:412-6.

(379)

Footnote 380

Phillips DF. "New look" reflects changing style of patient safety enhancement. J Am Med Assoc 1999;281:217-9.

(380)

Footnote 381

Chow KY, Lee CE, Ling ML, et al. Outbreak of severe acute respiratory syndrome in a tertiary hospital in Singapore, linked to an index patient with atypical presentation: Epidemiological study. Brit Med J 2004;328:195.

(381)

Footnote 382

Shen Z, Ning F, Zhou W, et al. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis 2004;10:256-60.

(382)

Footnote 383

Chen Y-C, Huang L-M, Chan C-C, et al. SARS in hospital emergency room. Emerg Infect Dis 2004;10:782-8.

(383)

Footnote 384

Mayer R, Geha R, Helfand M, et al. Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococci. Am J Infect Control 2003;31:221-5.

(384)

Footnote 385

Isaacs D, Dickson H, O'Callaghan C. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991;66:227-31.

(385)

Footnote 386

CDC. Guidelines for Preventing Opportunistic Infections Amoung Hematopoietic Stem Cell Transplant Recipients. MMWR 2000;49:1-95.

(386)

Footnote 387

Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997;102:48-54.

(387)

Footnote 388

McGeer A, et al. Vancomycin-resistant enterococci. Semin Respir Infect 2000;15:314-26.

(388)

Footnote 389

Boyce JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46-54.

(389)

Footnote 390

Murray-Leisure KA, Geib S, Graceley D. Control of epidemic methicillin –resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-50.

(390)

Footnote 391

Krasinski K, LaCouture R, Holzman RS, et al. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr 1990;116:894-8.

(391)

Footnote 392

Snydman DR, Greer C, Meissner C, et al. Prevention of transmission of respiratory syncytial virus in a newborn nursery. Infect Control Hosp Epidemiol 1988;9:105-8.

(392)

Footnote 393

Madge P, Paton JY, McColl JH, et al. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992;340:1079-83.

(393)

Footnote 394

Millar MR, Keyworth N, Lincoln C, et al. Methicillin-resistant Staphylococcus aureus in a regional neonatology unit. J Hosp Infect 1987;10:187-97.

(394)

Footnote 395

Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269-72.

(395)

Footnote 396

Jochimsen EM, Fish L, Manning K, et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 1999;20:106-9.

(396)

Footnote 397

Sample ML, Gravel D, Oxley C, et al. An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol 2002;23:468-70.

(397)

Footnote 398

Podnos YD, Cinat ME, Wilson SE, et al. Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect 2001;2:297-301.

(398)

Footnote 399

Doherty JA, Brookfield DS, Gray J, et al. Cohorting of infants with respiratory syncytial virus. J Hosp Infect 1998;38:203-6.

(399)

Footnote 400

Hall CB, Geiman JM, Douglas RG, et al. Control of nosocomial respiratory syncytial viral infections. Pediatr 1978;62:728-32.

(400)

Footnote 401

Buffington J, Chapman LE, Stobierski MG, et al. Epidemic keratoconjunctivitis in chronic care facility: Risk factors and measures for control. J Am Geriatr Soc 1993;41:1177-81.

(401)

Footnote 402

Pessoa-Silva CL, Dharan S, Hugonnet S, et al. Dynamics of bacterial hand contamination during routine neonatal care. Infect Control Hosp Epidemiol 2004;25:192-7.

(402)

Footnote 403

Update: Staphyloccoccus aureus with reduced susceptibility to vancomycin – United States, 1997. MMWR 1997;46:813-5.

(403)

Footnote 404

Hartstein AI, Denny MA, Morthland VH, et al. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995;16:405-11.

(404)

Footnote 405

Poutanen SM, Vearncombe M, McGeer AJ, et al. Nosocomial acquisition of methicillin-resistant Staphylococcus aureus during an outbreak of severe acute respiratory syndrome. Infect Control Hosp Epidemiol 2005;26:134-7.

(405)

Footnote 406

Olsen RJ, Lynch P, Coyle MB, et al. Examination gloves as barriers to hand contamination in clinical practice. J Am Med Assoc 1993;270:350-3.

(406)

Footnote 407

Patterson JE, Vecchio J, Pantelick EL, et al. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med 1991;91:479-83.

(407)

Footnote 408

Ehrenkranz NJ, Alfonso BC. Failure of bland soap handwash to prevent hand transfer of patient bacteria to urethral catheters. Infect Control Hosp Epidemiol 1991;12:654-62.

(408)

Footnote 409

Klein BS, Perloff WH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Eng J Med 1989;320:1714-21.

(409)

Footnote 410

Gala CL, Hall CB, Schnabel KC, et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. J Am Med Assoc 1986;256:2706-8.

(410)

Footnote 411

Agah R, Cherry JD, Garakian AJ, et al. Respiratory Syncytial Virus (RSV) Infection Rate in Personnel Caring for Children with RSV Infections – Routine Isolation Procedure vs. Routine Procedure Supplemented by Use of Masks and Goggles. Am J Dis Child 1987;141:695-7.

(411)

Footnote 412

Scheckler WE, Brimhall D, Buck AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Am J Infect Control 1998;26:47-60.

(412)

Footnote 413

Comite d'examen sur la prevention et le controle des infections nosocomiales. D'abord ne pas nuire... Les infections nosocomiales au Quebec, un probleme majeur de sante, une priorite. 2005.

(413)

Footnote 414

Zoutman D, et al. A comparison of infection control program resources, activities and antibiotic resistant organisms rates in Canadian acute care hospitals in 1999 and 2005; Pre- and post-severe acute respiratory syndrome. Am J Infect Control 2008;36:711-7.

(414)

Footnote 415

Friedman C, Barnette M, Buck AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: A consensus panel report. In: Abrutyn E, Goldmann DA, Scheckler WE, editors. Infection Control Reference Service. 2nd ed. Philadelphia: W.B. Saunders Company; 2001. p. 142-50.

(415)

Footnote 416

Public Health Agency of Canada. Essential Resources for Effective Infection Prevention and Control Programs; A Matter of Patient safety: A Discussion Paper. 2009.

(416)

Footnote 417

Provincial Infectious Diseases Advisory Committee (PIDAC). Best practices document for the management of Clostridium difficile in all health care settings. Ministry of Health and Long-Term Care; 2007. Report No.: Version 4.

(417)

Footnote 418

Accreditation Canada. Required Organizational Practices – Infection Control. 2010.

(418)

Footnote 419

Public Health Agency of Canada, National Advisory Committee on Immunization. Canadian immunization guide – 7th edition. 7 ed. 2006.

(419)

Footnote 420

Do A, Ciesielski C, Metler R, et al. Occupationally Acquired Human Immunodeficiency Virus (HIV) Infection: National Case Surveillance Data During 20 Years of the HIV Epidemic in the United States. Infect Control Hosp Epidemiol 2003;24:86-96.

(420)

Footnote 421

Hanson M. Guidelines Regarding HIV and Other Bloodborne Pathogens in Vascular/Interventional Radiology. J Vasc Interv Radiol 2003;14:S375-S384.

(421)

Footnote 422

Madan A, Raafat A, Hunt J, et al. Barrier precautions in trauma: Is knowledge enough? J Trauma 2002;52:540-3.

(422)

Footnote 423

Holodnick CL, Barkauskas V. Reducing percutaneous injuries in the OR by educational methods. AORN J 2000;72:461-75.

(423)

Footnote 424

US Department of Health and Human Services. NIOSH Alert: preventing needlestick injuries in health care settings. CDC; 2007. Report No.: NIOSH Publication No. 2000-108.

(424)

Footnote 425

Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: National evidence-based guidelines for preventing healthcare-associated Infections in NHS hospitals in England. J Hosp Infect 2007;65S:S1-S64.

(425)

Footnote 426

Braun BI, Kritchevsky SB, Wong ES, et al. Preventing Central Venous Catheter Associated Primary Bloodstream Infections: Characteristics of Practices Among Hospitals Participating in the Evaluation of Processes and Indicators in Infection Control (EPIC) Study. Infect Control Hosp Epidemiol 2003;24:926-35.

(426)

Footnote 427

Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S22-S30.

(427)

Footnote 428

Korniewicz DM, McLeskey SW. Latex allergy and gloving standards. Semin Perioper Nurs 1998;7:216-21.

(428)

Footnote 429

American Academy of Pediatrics, The American College of Obstetricians and Gynecologists. Inpatient Perinatal Care Services. In: Lockwood CJ, Lemons JA, editors. Guidelines for Perinatal Care. 6th ed. 2007. p. 19-65.

(429)

Footnote 430

Srinivasan A, McDonald LC, Jernigan D, et al. Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infect Control Hosp Epidemiol 2004;25:1020-5.

(430)

Footnote 431

Canadian Standards Association. Sterilization of health care products – Chemical indicators Part 1: General requirements. 2007. Report No.: Z11140-1-07.

(431)

Footnote 432

Rutala DR, Weber D. How to Assess Risk of Disease Transmission to Patients When There Is a Failure to Follow Recommended Disinfection and Sterilization Guidelines. Infect Control Hosp Epidemiol 2007;28:146-55.

(432)

Footnote 433

Carling PC, Parry MF, Von Beheren SM. Identifying Opportunities to Enhance Environmental Cleaning in 23 Acute Care Hospitals. Infect Control Hosp Epidemiol 2008;29:1-7.

(433)

Footnote 434

Rogers M, Weinstock DM, Eagen J, et al. Rotavirus outbreak on a pediatric oncology floor: possible association with toys. Am J Infect Control 2000;28:378-80.

(434)

Footnote 435

Khan FA, Khakoo RA, Hobbs GR. Impact of contact isolation on health care workers at a tertiary care center. Am J Infect Control 2006;34:408-13.

(435)

Footnote 436

Catalano G, Houston SH, Catalano MC, et al. Anxiety and depression in hospitalized patients in resistant organism isolation. South Med J 2003;96:141-5.

(436)

Footnote 437

Tuberculosis Prevention and Control, Public Health Agency of Canada, Canadian Lung Association/Canadian Thoracic Society. Canadian Tuberculosis Standards 6th Edition. 2007. Report No.: 6th Edition. Under revision.

(437)

Footnote 438

Public Health Agency of Canada (formerly Health Canada). Infection control guidelines for hand washing, cleaning, disinfection and sterilization in health care. Part of the Infection Control Guidelines Series. CCDR 1998;24S8:1-54.

(438)

Footnote 439

Population and Public Health Branch, Centre for Emergency Preparedness and Response, Health Canada. Laboratory Safety Guidelines – 3rd Edition. 2004. Report No.: 3rd Edition.

(439)

Footnote 440

Gilbride SJ, Lee BE, Taylor GD, et al. Successful Containment of a Norovirus Outbreak in an Acute Adult Psychiatric Area. Infect Control Hosp Epidemiol 2009;30:289-91.

(440)

Footnote 441

Drusin LM, Sohmer M, Groshen SL, et al. Nosocomial hepatitis A infection in a paediatric intensive care unit. Arch Dis Child 1987;62:690-5.

(441)

Footnote 442

Doebbeling BN, Li N, Wenzel RP. An outbreak of hepatitis A among HCW: risk factors for transmission. Am J Public Health 1993;83:1679-84.

(442)

Footnote 443

Jefferson T, Foxlee R, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database for Systematic Reviews [computer file] 2007;(4).

(443)

Footnote 444

Williams I, Perz JF, Bell BP. Viral hepatitis transmission in ambulatory healthcare settings. Clin Infect Dis 2004;38:1592-8.

(444)

Footnote 445

Ayliffe GAJ, Babb JR, Quoraishi AH. A test for 'hygienic' hand disinfection. J Clin Pathol 1978;31:923-8.

(445)

Footnote 446

Rotter ML. Hygienic hand disinfection. Infect Control 1984;5:18-22.

(446)

Footnote 447

Larson EL, Eke PI, Laughon BE. Efficacy of alcohol-based hand rinses under frequent-use conditions. Antimicrob Agents Chemother 1986;30:542-4.

(447)

Footnote 448

Larson EL, Eke PI, Wilder MP, et al. Quantity of soap as a variable in handwashing. Infect Control 1987;8:371-5.

(448)

Footnote 449

Ayliffe GA, Babb JR, Davies JG, et al. Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 1988;11:226-43.

(449)

Footnote 450

Zaragoza M, Sallés M, Gomez J, et al. Handwashing with soap or alcoholic solutions? A randomized clinical trial of its effectiveness. Am J Infect Control 1999;27:258-61.

(450)

Footnote 451

Ojajärvi J. Effectiveness of hand washing and disinfection methods in removing transient bacteria after patient nursing. J Hyg (Lond) 1980;85:193-203.

(451)

Footnote 452

Grohskopf LA, Roth VR, Feikin DR, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Eng J Med 2001;344:1491-7.

(452)

Footnote 453

Weaver G. Value of the face mask and other measures. J Am Med Assoc 1918;24:218-30.

(453)

Footnote 454

De Fijter S, DiOrio M, Carmean J, et al. Bacterial Meningitis After Intrapartum Spinal Anesthesia – New York and Ohio, 2008-2009. MMWR 2010;59:65-9.

(454)

Footnote 455

Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control 2001;29:312-5.

(455)

Footnote 456

Ministry of Health and Long-Term Care. Infection Prevention and Control Best Practices for Personal Services Settings. 2009.

(456)

Footnote 457

Hayden M, Blom DW, Lyle E, et al. Risk of hand or glove contamination after contact with patients colonized with VRE or the colonized patient's environment. Infect Control Hosp Epidemiol 2008;29:149-54.

(457)

Footnote 458

McFarland LV, Mulligan ME, Kwok RYY, et al. Nosocomial acquisition of Clostridium difficile infection. N Eng J Med 1989;320:204-10.

(458)

Footnote 459

Casewell M, Phillips I. Hands as a route of transmission for Klebsiella species. Br Med J 1977;2:1315-7.

(459)

Footnote 460

Broyles JM, O'Connell KP, Korniewicz DM. PCR-based method for detecting viral penetration of medical exam gloves. J Clin Microbiol 2002;40:2725-8.

(460)

Footnote 461

Neal JG, Jackson EM, Suber F, et al. Latex glove penetration by pathogens: A review of the literature. J Long Term Eff Med Implants 1998;84:233-40.

(461)

Footnote 462

Jurkovich P. Home-versus hospital-laundered scrubs: A pilot study. MCN Am J Matern Child Nurs 2004;29:106-10.

(462)

Footnote 463

Nicas M, Best D. A study quantifying hand-to-face contact rate and its potential application to predicting respiratory tract infection. J Occup Environ Med 2008;5:347-52.

(463)

Footnote 464

Rutala WA, Weber DJ. Surface disinfection: Should we do it? J Hosp Infect 2001;48:S64-S68.

(464)

Footnote 465

Dassut B. The Implementation of a Commode Cleaning and Identification System. Nurs Times 2004;100:47.

(465)

Footnote 466

Samore MH, Venkataraman L, DeGirolami PC, et al. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100:32-40.

(466)

Footnote 467

Ray AJ, Hoyen CK, Taub TF, et al. Nosocomial Transmission of Vancomycin-Resistant Enterococci from Surfaces. J Am Med Assoc 2002;287:1400-1.

(467)

Footnote 468

Weber DJ, Sickbert-Bennett E, Gergen MF, et al. Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. J Am Med Assoc 2003;289:1274-7.

(468)

Footnote 469

Montesinos I, Salido E, Delgado T, et al. Epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital in the Canary Islands. Infect Control Hosp Epidemiol 2003;24:667-72.

(469)

Footnote 470

Hotchkiss JR, Strike DG, Simonson DA, et al. An agent-based and spatially explicit model of pathogens dissemination in the intensive care unit. Crit Care Med 2005;33:168-76.

(470)

Footnote 471

Austin DJ, Bonten MJM, Weinstein RA, et al. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA 1999;96:6908-13.

(471)

Footnote 472

American Academy of Pediatrics, The American College of Obstetricians and Gynecologists. Infection Control. In: Lockwood CJ, Lemons JA, editors. Guidelines for Perinatal Care. 6th ed. 2007. p. 349-70.

(472)

Footnote 473

Boyce JM, Mermel LA, Zervos MJ. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16:634-7.

(473)

Footnote 474

Yap FH, Gomersall CD, Fung KS, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis 2004;39:511-6.

(474)

Footnote 475

Provincial Infectious Diseases Advisory Committee (PIDAC). Best Practices for Environmental Cleaning for Prevention and Control of Infections in all Health Care Settings. 2009.

(475)

Footnote 476

(476) Rampling A, Wiseman S, Davis L, et al. Evidence That Hospital Hygiene is Important in the Control of Methicillin-Resistant Staphylococcus aureus. J Hosp Infect 2001;49:109-16.

(476)

Footnote 477

Hall C, et al. Respiratory syncytial viral infection in children with compromised immune function. N Eng J Med 1986;315:77-81.

(477)

Footnote 478

Wood DJ, David TJ, Chrystie IL, et al. Chronic enteric virus infection in two T-cell immunodeficient children. J Med Virol 1988;24:435-44.

(478)

Footnote 479

Mori I, Matsumoto K, Sugimoto K, et al. Prolonged shedding of rotavirus in geriatric inpatient. J Med Virol 2002;67:613-5.

(479)

Footnote 480

Nichols WG, Corey L, Gooley T, et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001;98:573-8.

(480)

Footnote 481

Elizaga J, Olavarria E, Apperley J, et al. Parainfluenza virus 3 infection after stem cell transplant: Relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis 2001;32:413-8.

(481)

Footnote 482

Oishi I, Kimura T, Murakami T, et al. Serial observations of chronic rotavirus infection in an immunodeficient child. Microbiol Immunol 1991;35:953-61.

(482)

Footnote 483

Lacey S, Flaxman D, Scales J, et al. The usefulness of masks in preventing transient carriage of epidemic methicillin-resistant Staphylococcus aureus by healthcare workers. J Hosp Infect 2001;48:308-11.

(483)

Footnote 484

Siegel J, Rhinehart E, jackson M, et al. Management of multidrug-resistant organisms in healthcare settings, 2006. CDC 2006;1-74.

(484)

Footnote 485

Tan YM, Chow PK, Tan BH, et al. Management of inpatients exposed to an outbreak of severe acute respiratory syndrome (SARS). J Hosp Infect 2004;58(3):210-5.

(485)

Footnote 486

Menzies D, Fanning A, Yuan L, et al. Hospital Ventilation and Risk for Tuberculous Infection in Canadian Health Care Workers. Ann Intern Med 2000;133:779-89.

(486)

Footnote 487

Pavelchak N, DePersis RP, London M, et al. Identification of factors that disrupt negative air pressurization of respiratory isolation rooms. Infect Control Hosp Epidemiol 2000;21:191-5.

(487)

Footnote 488

Rice N, Streifel A, Vesley D. An evaluation of hospital special ventilation- room pressures. Infect Control Hosp Epidemiol 2001;22:1923.

(488)

Footnote 489

Fenner F, Henderson DA, Arita I, et al. The epidemiology of smallpox. In: World Health Organization, editor. Smallpox and its eradication.Switerland: 1988. p. 169-208.

(489)

Footnote 490

Brodkin R. Zoster causing varicella. Current Dangers of contagion without isolation. Arch Dermatol 1963;88:322-4.

(490)

Footnote 491

Suzuki K, Yoshikawa T, Tomitaka A, et al. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 2004;189:1009-12.

(491)

Footnote 492

American Academy of Pediatrics, Pickering LK. Red Book: Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, Illinois: 2009.

(492)

Footnote 493

Stead WW. Tuberculosis among elderly persons: An outbreak in a nursing home. Ann Intern Med 1981;94:606-10.

(493)

Footnote 494

Bentley DW. Tuberculosis in long-term care facilities. Infect Control Hosp Epidemiol 1990;11:42-6.

(494)

Footnote 495

Dooley SW, Castro KG, Hutton MD, et al. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR 1990;39:1-29.

(495)

Footnote 496

Smith P, Bennet G, Bradley S, et al. SHEA/APIC Guideline: Infection Prevention and Control in the Long-Term Care Facility. Am J Infect Control 2008;36:504-35.

(496)

Footnote 497

Heymann DL. Control of Communicable Diseases in Man. 19th ed. Washington, DC: American Public Health Association; 2008.

(497)

Footnote 498

Public Health Agency of Canada (formerly Health Canada). Tool kit for critical appraisal. 2011. Ref Type: Unpublished Work

(498)

Footnote 499

Stellman JM. Encyclopaedia of Occupational Health and Safety (4th Edition). International Labour Office 1998 Available from: URL: http://www.ilocis.org/en/contilo.html

(499)

Footnote 500

DeCastro MG, Iwamoto P. Aseptic Technique. APIC Text of infection Control & Epidemiology. 2nd ed. Washington: Association for Professionals In Infection Control & Epidemiology (APIC); 2005. p. 20-1-20-3.

(500)

Footnote 501

Wooten MK, Hawkins K. Clean versus sterile; Management of chronic wounds. J Wound Ostomy Continence Nurs 2001;28:24A-6A.

(501)

Footnote 502

Valenti WM, Menegus MA. Nosocomial viral infections: IV. Guidelines for cohort isolation, the communicable disease survey, collection and transport of specimens for virus isolation, and considerations for the future. Infect Control 1981;2:236-45.

(502)

Footnote 503

Wells WF. On air-borne infection. II. Droplets and droplet nuclei. Am J Hyg 1934;20:611-8.

(503)

Footnote 504

World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. Geneva; 2009.

(504)

Footnote 505

Rogers B. Health hazards in nursing and health care: An overview. Am J Infect Control 1997;25:248-61.

(505)

Footnote 506

Levy BS, Wegman DH, Baron SL, et al. Occupational and environmental health: recognizing and preventing disease and injury. 5 ed. Lippincott Williams & Wilkins; 2006.

(506)

Footnote 507

Stedman's Medical Dictionary. 28th ed. Lippincott Williams and Wilkins; 2005.

(507)

Footnote 508

National Institute for Occupational Health and Safety (NIOSH). NIOSH Respirator Selection Logic. 2004.

(508)

Footnote 509

Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings: recommendations of the healthcare infection control practices advisory comittee and the HICPAC/SHEA/APIC/IDSA hand hygiene task force. MMWR 2002;51:1-47.

(509)

Footnote 510

Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. Can Med Assoc J 2004;171:51-8.

(510)

Footnote 511

Gravel D, Miller M, Clostridium difficile Surveillance Working Group. Canadian nosocomial infection surveillance program final report. Clostridium difficile associated diarrhea in acute-care hospitals participating in CNISP: November 1, 2004 to April 30, 2005. 2007.

(511)

Footnote 512

Institut national de santé publique du Québec. Surveillance des diarrhées associées à Clostridium difficile au Québec – Bilan du 17 août 2008 au 15 août 2009. 2009.

(512)

Footnote 513

Hyland M, Ofner-Agnostini ME, Miller M, et al. N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project. Can J Infect Dis 2001;12:81-8.

(513)

Footnote 514

Miller M, Gravel D, Mulvey M, Simor AE, Taylor G, McGeer A, et al. Ongoing Epidemiology of Healthcare-Associated C. difficile in Canada: Evidence for Further Spread of NAP1/027 and Coincident Increased Mortality. 19th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, San Diego, California, March 19-22, 2009. Ref Type: Abstract

(514)

Footnote 515

Miller MA, Hyland M, Ofner-Agostini M, et al. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002;23:137-40.

(515)

Footnote 516

Pepin J, Valiquette L, Cossette B. Mortality attributes to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Can Med Assoc J 2005;173:1037-42.

(516)

Footnote 517

Simor AE, Bradley SF, Strausbaugh LJ, et al. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002;23:696-703.

(517)

Footnote 518

Loo V-G, Poirier L, Poirier L, et al. A Predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Eng J Med 2005;353:2442-9.

(518)

Footnote 519

Pepin J, Valiquette L, Alary M-E, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004;171:466-72.

(519)

Footnote 520

Kato H, Kato N, Watanabe K, et al. Application of Typing by Pulsed-Field Gel Electrophoresis to the Study of Clostridium difficile in a Neonatal Intensive Care Unit. J Clin Microbiol 1994;32:2067-70.

(520)

Footnote 521

Enad D, Meislich D, Brodsky NL, et al. Is Clostridium difficile a Pathogen in the Newborn Intensive Care Unit? A Prospective Evaluation. J Perinatol 1997;17:355-9.

(521)

Footnote 522

Langley JM, LeBlanc JC, Hanakowski M, et al. The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Infect Control Hosp Epidemiol 2002;23:660-4.

(522)

Footnote 523

Shadel BN, et al. Surveillance for vancomycin-resistant enterococci: Type, rates, costs and implications. Infect Control Hosp Epidemiol 2006;27:1068-75.

(523)

Footnote 524

Bignardi G. Risk factors for Clostridium difficile infection. J Hosp Infect 1998;40:1-15.

(524)

Footnote 525

Anand A, et al. Clostridium difficile infection associated with antineoplastic chemotherapy: A review. Clin Infect Dis 1993;17:109-13.

(525)

Footnote 526

Blot E, et al. Outbreak of Clostridium difficile-related diarrhea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect 2003;53:187-92.

(526)

Footnote 527

Sharma AK, et al. Clostridium difficile diarrhea after use of tacrolimus following renal transplantation. Clin Infect Dis 1998;27:1540-1.

(527)

Footnote 528

McFarland LV, et al. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Hosp Infect 1990;162:678-84.

(528)

Footnote 529

Barbut F, et al. Epidemiology of Clostridium-difficile associated infections. Clin Microbiol Infect 2001;7:405-10.

(529)

Footnote 530

Riggs M, et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among LTC facility residents. Clin Infect Dis 2007;45.

(530)

Footnote 531

Brooks SE, Veal RO, Kramer M, et al. Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992;13:98-103.

(531)

Footnote 532

Dubberke E, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007;35:315-8.

(532)

Footnote 533

Johnson S, Clabots CR, Linn FV, et al. Nosocomial clostriduim difficile colonisation and disease. Lancet 1990;336:97-100.

(533)

Footnote 534

Romanenko VI. Preservation of bacterial spores in 96% ethyl alcohol. Mikrobiologiia 1982;51:691-192.

(534)

Footnote 535

Boyce JM, Ligi C, Kohan C, et al. Lack of association between the increased incidence of Clostridium-difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 2006;27:479-83.

(535)

Footnote 536

Gopal Roa G, Jeanes A, Osman M, et al. Marketing and hand hygiene in hospitals – a case study. J Hosp Infect 2002;50:42-7.

(536)

Footnote 537

Gordin FM, Schultz ME, Huber RA, et al. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol 2005;26:650-3.

(537)

Footnote 538

Stone SP, et al. The ORION statement: Guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007;59:883-40.

(538)

Footnote 539

Fowler S, et al. Successful use of feedback to improve antibiotic prescribing and reduce C. difficile infection: A controlled interrupted time series. J Antimicrob Chemother 2007;59:990-5.

(539)

Footnote 540

Comité sur les infections nosocomiales du Québec. Prévention et contrôle de la diarrhée nosocomiale associée au Clostridium difficile au Québec – Lignes directrices pour les établissements de soins. 3e ed. Institut national de santé publique du Québec; 2005.

(540)

Footnote 541

Provincial Infectious Diseases Advisory Committee (PIDAC). Routine Practices and Additional Precautions in All Health Care Settings. Ontario Ministry of Health and Long-Term Care; 2010.

(541)

Footnote 542

Calfee D, et al. Strategies to prevent transmissin of methicillin-resistant Staphylococcus aureau in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S62-S80.

(542)

Footnote 543

Anderson D, et al. Strategies to prevent surgical site infection in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S51-S61.

(543)

Footnote 544

Goetghebeur PA, et al. Methicillin-resistant staphylococcua aureus: A public health issue with economic consequences. Can J Infect Dis and Med Micro 2007;18:27-34.

(544)

Footnote 545

Public Health Agency of Canada. Surveillance for Methicillin-resistant Staphylococcus aureus (MRSA) in Patients Hospitalized in Canadian Acute-Care Hospitals Participating in CNISP 2006-2007 Preliminary Results. 2008.

(545)

Footnote 546

Thompson RL, et al. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-17.

(546)

Footnote 547

Boyce JM, Jackson MM, Pugliese G, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol 1994;15:105-15.

(547)

Footnote 548

Monnet DL. Monnet DL Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control ICHE 1998;19:552-9. Infect Control Hosp Epidemiol 1998;19:552-9.

(548)

Footnote 549

Barton M, Hawkes M, Moore D, et al. Guidelines for the Prevention and Management of Community-Associated Methicillin Resistant: A Perspective for Canadian Health Care Practitioners. Can J Infect Dis Med Microbiol 2006;17:4C-24C.

(549)

Footnote 550

Cetinkaya Y. Vancomycin-Resistant Enterococci. Clin Microbiol Rev 2000;13:686-707.

(550)

Footnote 551

Public Health Agency of Canada. Surveillance for Vancomycin Resistant Enterococci (VRE) in Patients Hospitalized in Canadian Acute-Care Hospitals Participating in CNISP 2006 Results. 2008.

(551)

Footnote 552

Gould FK, Freeman R. Nosocomial infection with microsphere beds. Lancet 1993;342:241-2.

(552)

Footnote 553

Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195-200.

(553)

Footnote 554

Hayden MK, Bonten JM, Blom DW, et al. Reduction in acquisition of vancomycin-resistant Enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006;42:1552-60.

(554)

Footnote 555

Hyle E, Lipworth A, Zaoutis T, et al. Risk Factors for Increasing Multidrug Resistance among Extended-Spectrum ß-lactamase-Lactamase- Producing Escheria coli and Klebsiella species. Clin Infect Dis 2005;40:1317-24.

(555)

Footnote 556

Pitout JDD, Gregson DB, Church DL, et al. Community-Wide Outbreaks of Clonally Related CTX-M-14 Lactamase-Producing Escherichia coli Strains in the Calgary Health Region. J Clin Microbiol 2005;43:2844-9.

(556)

Footnote 557

Simor AE, Lee M, Vearncombe M, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002;23:261-7.

(557)

Footnote 558

Lyytikainen O, Koljalg S, Harma M, et al. Outbreak Caused by Two Multi-Resistant Acinetobacter baumannii Clones in a Burns Unit: Emergency of Resistance to Imipenem. J Hosp Infect 1995;31:41-54.

(558)

Footnote 559

Sherertz R, et al. An Outbreak of Infections with Acinetobacter calcoaceticus in Burn Patients: Contamination of Patients' Mattresses. J Infect Dis 1985;151.

(559)

Footnote 560

Green K, McGeer A. Infection control surveillance – where do we go from here? Can J Infect Control 1997;59-64.

(560)

Footnote 561

Hota S, Hirji Z, Stockton K, et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol 2009;30:25-33.

(561)

Footnote 562

Fierobe L, Lucet J-C, Decre D, et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect Control Hosp Epidemiol 2001;22:35-40.

(562)

Footnote 563

McCracken M, DeCorby M, Fuller J, et al. Identification of Multidrug- and Carbapenem-Resistant Acinetobacter baumannii in Canada: Results from CANWARD 2007. J Antimicrob Chemother 2009;64:552-5.

(563)

Footnote 564

Kumarasamy K, Toleman MA, Walsh TR, et al. Emergence of a New Antibotic Resistance Mechanism in India, Pakistan, and the UK: A Molecular, Biological, and Epidemiological Study. Lancet Infect Dis 2010;Advance Online Publication(August 11, 2010):1-6.

(564)

Footnote 565

Zingg W, Columbo C, Jucker T, et al. Impact and outbreak of norovirus infection on hospital resources. Infect Control Hosp Epidemiol 2005;26:263-7.

(565)

Footnote 566

Chadwick PR, McCann R. Transmission of a small round structured virus by vomiting during a hospital outbreak of gastroenteritis. J Hosp Infect 1994;26:251-9.

(566)

Footnote 567

Green J, et al. The role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay. J Hosp Infect 1998;39:39-45.

(567)

Footnote 568

Khanna N, Goldenberger D, Graber P, et al. Gastroenteritis Outbreak with Norovirus in a Swiss University Hospital with a Newly Identified Virus Strain. J Hosp Infect 2003;55:131-6.

(568)

Footnote 569

Green K, Belliott G, Taylor J, et al. A predominant role for Norwalklike viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis 2002;185:133-46.

(569)

Footnote 570

Calderon-Margalit R, Sheffer R, et al. A large-scale gastroenteritis outbreak associated with Norovirus in nursing homes. Epidemiol Infect 2005;133:35-40.

(570)

Footnote 571

Albers MK. An unwanted visitor: agressive infection control strategies are needed to shorten the hospital visit of the easily spread norovirus. Can Nurs 2004;100:21-6.

(571)

Footnote 572

Kuusi M, Nuorti JP, Maunula L, et al. A prolonged outbreak of norwalk-like calicivirus (NLV) gastroenteritis in a rehabilitation centre due to environmental contamination. Epidemiol Infect 2002;129:133-8.

(572)

Footnote 573

Gehrke C, Steinmann J, Goroncy-Bermes P. Inactivation of felinecalicivirus, a surrogate of norovirus (formerlyNorwalk-like virus), by different types of alcohol in vitro and vivo. J Hosp Infect 2004;56:49-55.

(573)

Footnote 574

Sandora TJ, Shih M-C, Goldmann DA. Reducing absenteeisin from gastrointestinal and respiratory illness in elementary school students; A randomized controlled trial of an infection-control intervention. Pediatr 2008;121:e1555-e1562.

(574)

Footnote 575

Lages SLS, Ramakrishnan MA, Goyal SM. In-vivo efficacy of hand sanitizers against feline calcivirus; a surrogate for norovirus. J Hosp Infect 2008;68:159-63.

(575)

Footnote 576

Kampf G, Grotheer D, Steinmann J. Efficacy of three ethanol-based hand rubs against feline calicivirus, a surrogate virus for norovirus. J Hosp Infect 2005;60:144-9.

(576)

Footnote 577

Kramer A, Galabov AS, Sattar Sa, et al. Virucidal activity of a new hand disinfectant with reduced ethanol content: comparison with other alcohol-based formulations. J Hosp Infect 2006;62:98-106.

(577)

Footnote 578

Rodriguez EM, Parrott C, Rolka H, et al. An outbreak of viral gastroenteritis in a nursing home: importance of excluding ill employees. Infect Control Hosp Epidemiol 1996;17:587-92.

(578)

Footnote 579

Kaplan JE, Schonberger LB, Varano G, et al. An outbreak of acute nonbacterial gastroenteritis in a nursing home: demonstration of person-to-person transmission by temporal clustering of cases. Am J Epidemiol 1982;116:940-7.

(579)

Footnote 580

Gleizes O, Desselberger U, Tatochenko V, et al. Nosocomial rotavirus infection in European countries: A review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Ped Infect Dis J 2008;25(1 Suppl):S12-S21.

(580)

Footnote 581

Chandran A, Heinzen RR., Santosham M, et al. Nosocomial rotavirus infections: A systematic review. J Pediatr 2006;149:441-7.

(581)

Footnote 582

Abbas AMA, et al. An outbreak of rotavirus infection in a geriatric hospital. J Hosp Infect 2008;9:76-80.

(582)

Footnote 583

Bishop RF. Natural history of human rotavirus infection. Arch Virol 1981;21:119-28.

(583)

Footnote 584

Bishop RF. Quantitative aspects of rotavirus excretion in childhood diarrhoea. Acta Paediatr 1981;70:717-21.

(584)

Footnote 585

Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43:1-132.

(585)